Artificial Intelligence | News | Insights | AiThority

[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Browsing Tag

Envisagenics

Machine Learning

Envisagenics, Cancer Research Horizons, and Queen Mary University of London Announce Strategic…

AIT News Desk Dec 13, 2022

Envisagenics, an AI-driven biotechnology company that delivers therapies for RNA splicing diseases, announced a research collaboration agreement with…

Machine Learning

Envisagenics Announces Research Collaboration with Bristol Myers Squibb

AIT News Desk Nov 29, 2022

Envisagenics, an Artificial Intelligence (AI)-driven biotechnology company that delivers therapies for RNA splicing diseases, announced a research…

Machine Learning

Envisagenics is Awarded Another SBIR Grant From the National Cancer Institute to Commercialize its…

AIT News Desk Aug 2, 2022

Envisagenics, Inc., a New York-based biotechnology company leveraging artificial intelligence (AI) and RNA-splicing analytics for discovery and…